BioInvest

Celaid Therapeutics Secures ¥1.05 Billion in Series B First Close to Advance Next-Generation Stem Cell Therapies

Celaid Therapeutics Inc. announced the successful completion of the 1st Close of its Series B financing round, raising JPY 1.055 billion (US...

 October 08, 2025 | News

Eli Lilly Opens 82,500-Square-Foot Gateway Labs in San Diego to Support Early-Stage Biotech Innovation

New 82,514 square foot facility will accommodate up to 15 biotech companies to fuel next-generation medicines  Gateway Labs model provides flexible l...

 September 29, 2025 | News

Amgen Announces $650 Million U.S. Manufacturing Expansion, Creating 750 New Jobs

Amgen announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs. The planned investment will supp...

 September 29, 2025 | News

Merck Opens €150 Million Climate-Neutral Filter Manufacturing Facility in Cork

Part of company’s €440 million investment in Ireland, strengthens Merck’s in-region-for-region supply resilience Merck’s firs...

 September 23, 2025 | News

Mabwell and Aditum Bio Launch Kalexo Bio with $1 Billion siRNA Deal for Dyslipidemia and ASCVD

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio announced the launch of Kalexo Bio, a new company formed in conjunction with an exc...

 September 18, 2025 | News

Eli Lilly to Invest $5 Billion in New Virginia API and Bioconjugate Manufacturing Facility

New site in Virginia's Goochland County will develop active pharmaceutical ingredients (API) in the U.S. for cancer, autoimmune and other ad...

 September 17, 2025 | News

Shineco Strikes $8.7M R&D Deal and Builds Global Bridge with Singapore’s BICC

Shineco Inc., a developer and commercializer of induced pluripotent stem cell (iPSC) technology platforms, announced two major strategic advances. Its subs...

 September 15, 2025 | News

YolTech Raises $45 Million in Series B Funding to Propel In Vivo Gene-Editing Therapies

YolTech Therapeutics, a clinical-stage biotech company pioneering in vivo genome editing therapies, today announced the closing of its approximately $...

 September 12, 2025 | News

The State of Biotech and Life Science Jobs in Asia Pacific – 2025

In 2025, Asia-Pacific has emerged as the fastest-growing hub for biotech and life sciences employment, fuelled by a powerful combination of government supp...

 September 09, 2025 | Report

Epigenic Therapeutics Raises $60 Million in Series B Financing to Advance Epigenetic Medicine Pipeline

Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series ...

 September 09, 2025 | News

Sirnaomics Secures HKD 138 Million Strategic Investment from Bloomage Biotech

Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of advanced RNAi therapeutics, announced that it has entered into a ...

 September 09, 2025 | News

Servier Acquires Kaerus Bioscience’s KER-0193 in Deal Worth Up to $450M

Servier, an independent international pharmaceutical group governed by a foundation, announced that it has entered into a definitive agreement with Kaerus ...

 September 09, 2025 | News

Stallergenes Greer and Nuance Pharma Enter Exclusive Partnership to Develop and Commercialise Actair® in China

Stallergenes Greer, a global leader in allergy therapeutics, and Nuance Pharma, an innovation-focused biopharmaceutical company based in China, announced t...

 September 05, 2025 | News

Gilead Sciences Breaks Ground on New Foster City Technical Development Center as Part of $32B U.S. Investment

New Bay Area Building Marks Significant Progress as Part of $32 Billion U.S. Investment Projected to Create $43 Billion in Economic Value Gilead Sciences ...

 September 04, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close